top of page
Discover the Latest in Biomedical Research Innovation
Search


How to Report Your Statistics in a Methods Section Reviewers Won't Question
Reviewers examining 100 clinical papers found 65% needed revisions just to explain what their statistical tests were for, and 64% had omitted effect sizes entirely. Statistical reporting problems are rarely about running the wrong analysis; they're about not writing down enough for a reader to judge it. Here's what belongs in the section, built on the SAMPL guidelines: seven things to state in your methods, the results formats that draw fewest queries, and a template you can
Sep 45 min read


ANCOVA vs. Multiple Regression: Which One Are You Actually Running?
Run an ANCOVA and a multiple regression on the same data, specified equivalently, and you get the same F, the same p, and the same coefficients. They are one model with two traditions, and dummy coding is the bridge. So the real question isn't which is correct but which framing makes your result clearest. This piece covers why they're equivalent, what genuinely differs, and how to describe your model so reviewers from either tradition can follow it.
Aug 286 min read


How to Run an ANCOVA in GraphPad Prism (and How It Compares to Doing It with Sophie)
Hunted through Prism's Analyze menu for ANCOVA? It isn't there, and GraphPad's own FAQ confirms they've never shipped one. Prism can still do it, through two documented routes most users never find: the simple-linear-regression slopes test for the parallel-slopes assumption, and multiple regression with dummy-coded groups for the adjusted comparison. Here are both step by step, plus an honest comparison with describing the same analysis in plain language instead.
Aug 216 min read


A Researcher's Guide to Multiple Regression for Dose-Response and Covariate Analysis
Most bench scientists reach for a t-test or ANOVA by reflex, but plenty of real experiments have a continuous dose, groups that differ at baseline, or nuisance variation eating the power. Multiple regression handles all three, and ANOVA and ANCOVA turn out to be special cases of it. This guide covers when regression earns its place, how to read coefficients honestly, the two covariate mistakes that invalidate an analysis, and why dose-response needs a 4PL curve, not a line.
Aug 177 min read


ANCOVA Protocol: A Step-by-Step for Comparing Groups While Controlling for a Covariate
Your treated and control wells started at different confluence, so comparing endpoints with a plain ANOVA measures your treatment effect plus the head start. ANCOVA fixes that by adjusting for a continuous covariate, and usually buys power too. This step-by-step ANCOVA protocol runs 24 numbered steps from covariate choice through reporting, with the assumption checks in the order they need to happen, including the parallel-slopes test most people skip.
Aug 127 min read


The 5 Most Common P-Value Mistakes in Biomedical Papers (and How to Avoid Each)
When medical residents were surveyed on interpreting a p-value, 88% were confident they understood it and 100% got it wrong. That gap is why p-value mistakes survive peer review: nobody thinks they're making one. This piece covers the five most common errors in biomedical papers, several measured at scale in real journals: the inverse probability fallacy, the replication fallacy, 'trending toward significance', p-hacking, and treating 0.05 as a bright line.
Aug 38 min read


Do You Still Need to Learn GraphPad Prism? Use This AI Alternative to Runs Your Stats in Plain English, Instead!
Walk into most labs and you'll find a multi-seat GraphPad Prism license that only one or two people can actually use. Prism is powerful, but its learning curve takes months, so the license sits idle while everyone waits on the lab's 'stats person.' This piece makes the case for a different GraphPad Prism alternative: Sophie, the AI you just talk to. Describe your experiment in plain English and it picks the right test, runs it, and explains the result.
Jun 297 min read


Statistical Significance vs. Biological Significance: Why a p < 0.05 Can Still Be Meaningless
A small p-value tells you a difference is probably real, not that it's big enough to matter. Statistical significance asks whether an effect is distinguishable from noise; biological significance asks whether it's large enough to change a cell, a patient, or a conclusion. Because the p-value shrinks as your sample grows, a big enough study can stamp p < 0.05 on a difference that means nothing. Here's why, with real examples, and what to report instead: effect size and confide
Jun 248 min read


Tukey vs. Bonferroni: The Right Choice for Biomedical Research
Struggling to choose between Tukey's HSD and Bonferroni for your biomedical research? Stop guessing. This guide breaks down exactly when to use each post-hoc test to avoid false positives and maximize statistical power. Learn why Tukey is best for "all-vs-all" exploration while Bonferroni shines in planned comparisons. Perfect for optimizing your Western blot and assay data analysis.
Mar 306 min read


When to use t-test vs ANOVA: Choosing the Right Statistical Test
Struggling to choose between a t-test and ANOVA for your data analysis? You're not alone! This guide breaks down the key differences between these two essential statistical tests. Learn when to use a t-test for comparing two groups and when to use ANOVA for three or more groups. We'll also cover why you shouldn't just run multiple t-tests and whether you can use ANOVA for two groups. Boost your data science skills and make sure you're using the right test every time.
Aug 18, 20254 min read
bottom of page
